Epilepsy , 118121
Additionally, BPC-157 has shown potential to reduce inflammation, support collagen production, and improve the overall integrity of connective tissue
Compounded GLP-1 medications produce the same side effect profile as brand-name versions because they contain identical active ingredients
It works by: Stimulating angiogenesis (the growth of new blood vessels) Improving blood flow to injured areas Supporting the migration and proliferation of healing cells For orthopedic patients, this could mean: Faster recovery from tendon or ligament injuries Improved outcomes after orthopedic procedures Reduced downtime for athletes and active individuals Importantly, research has shown that BPC-157 is consistently effective across multiple models of both acute and chronic injuryincluding injuries to the gastrointestinal tract, where it has been tested via multiple delivery routes (oral, injection, and local application)
It targets three key receptors, GLP-1, GIP, and GCG (glucagon)
Sikiri P, Hahm KB, Blagaic AB, et al